John Sterling

A team of researchers say they have solved the mystery of what drives the genomic rearrangements causing the aggressive development and evolution of osteosarcoma tumors.

Credit: Ake Ngiamsanguan/Getty Images Researchers say they have identified new genetic risk factors for depression across all major global

Scientists at Lyndra Therapeutics say that the company's LYNX® drug delivery platform is modular and has the potential for broad applicability across

The study's findings are crucial in the rapidly emerging field of developing disease-modifying therapies that target microglia.

Colored scanning electron micrograph (SEM) of Saccharomyces cerevisiae. Scientists created the world's first synthetic eukaryotic genome from

Kraig Biocraft Labs genetically engineers spider silk materials for use in a spectrum of markets, including textiles, defense, and medical sectors. [Yipengge/Getty Images]

Neuromorphic computing is a brain-inspired approach to hardware and algorithm design that efficiently realizes artificial neural networks. [MF3D/Getty Images]

Credit: Azman Jaka/Getty Images miRecule, a biotechnology company focusing on RNA therapies, and GBI Biomanufacturing, a CDMO, partnered to

Arabidopsis thaliana illuminated with natural light in the field. The small flowering plant is native to Eurasia and Africa and serves as a popular model organism in plant biology and genetics. [Cesar Martinez Amor/Getty Images]

Credit: Metamorworks/Getty Images Rentschler Biopharma is withdrawing from the field of cell and gene therapy, ceasing operations at its